Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

NCT04620655 is registered in ClinicalTrials.gov with Min Xiang as lead sponsor.

NCT NCT04620655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL
Lead sponsor
Min Xiang
Phase
Not applicable
Overall status
Unknown status
Start date
November 15, 2020
Completion date
November 15, 2022
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

t acute lymphoblastic leukemia, t-lymphoblastic lymphoma